RENN Health review
The homepage and the semaglutide page give different figures for the same product.
The verdict
RENN Health publishes semaglutide as low as $149 a month on its homepage and as low as $199 on its semaglutide page. Tirzepatide is $199 and both pages agree on that.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- From $149/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
RENN Health sells both molecules by injection, with three and six-month bundles offered at stack discounts. Two of its pages disagree on one figure.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The pages state prices and bundles. The clinician is not described.
One product with two published prices is a disclosure problem before it is a pricing one. A reader who lands on the homepage plans from $149 and a reader who lands on the drug page plans from $199.
What happens when the dose goes up?
Both figures use as-low-as wording, so each is a floor rather than a rate. Nothing states what raises either, and with two floors in play the range is wider than any single page suggests.
What the price includes
The semaglutide figure fell to $149 on the homepage, while the drug-specific page still reads $199. Tirzepatide is $199 on both. Three and six-month bundles are described as carrying stack discounts without their figures being published. Confirm which semaglutide figure applies before ordering.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Both pages agree on tirzepatide
- Strength: Bundles are described as available
- Strength: Predictable monthly pricing is claimed
- Limitation: Two pages give different semaglutide figures
- Limitation: Both use as-low-as wording
- Limitation: Bundle discounts are not quantified
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about RENN Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who will confirm which figure applies before paying.
- Wrong for
- A reader planning from whichever page they happened to open.
The evidence behind what RENN Health prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How RENN Health compares
| Seller | Who it suits | Go |
|---|---|---|
| Remote Pharmacy | Readers prepared to get the billing term confirmed in writing before paying anything | See Remote Pharmacy → |
| Readers who want the flat claim shown at each tier rather than asserted once | See Renlo Health → | |
| Rejuve Meds | Readers who will prepay a year and have read the footnote under the label | See Rejuve Meds → |
More GLP-1 telehealth sellers reviews: Hello AlphaHelloWellnessHenry MedsHeros HealthHersHeva Health
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is semaglutide $149 or $199?
- The homepage says as low as $149 and the semaglutide page says as low as $199. Confirm which applies before ordering.
- Do the pages agree on anything?
- Yes. Tirzepatide is $199 on both the homepage and the tirzepatide page.
- What do the bundles cost?
- Three and six-month bundles are described as carrying stack discounts, without published figures.
- Is RENN Health expensive compared with other GLP-1 telehealth sellers?
- RENN Health publishes a starting figure of $149/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts RENN Health below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.